Biogen Is ‘Evaluating Strategic Options’ For Its Biosimilars Business

CEO Says ‘Formal Process Is Underway’ To Consider Selling To A New Owner

 
• By David Wallace
  
Sell decision - yes or no? Wooden blocks
Biogen is weighing whether to sell its biosimilars business • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products